Probiotics Vs. Placebo: Preventing Necrotizing Enterocolitis in a Premature Infant

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Oct 8

PMID 39376813

Authors

Sami Ullah

Inayatullah Khan

Ayesha Lnu

Jabran Ullah Khan

Annam Syed

Fatima Shafiq

Muhammad Khan

Fahad R Khan

Affiliations

Soon will be listed here.

Abstract

Background: Necrotizing enterocolitis (NEC) is a severe gastrointestinal condition primarily affecting preterm newborns, leading to significant morbidity and mortality.

Objective: This prospective cohort study aimed to evaluate the effectiveness of probiotics in preventing NEC in premature infants. Secondary objectives included assessing the impact on mortality, late-onset sepsis, duration of hospital stay, and weight gain.

Methods: The study was conducted at Lady Reading Hospital Medical Teaching Institute, Peshawar, from April 1, 2023, to March 31, 2024, involving 102 preterm infants. Participants were randomly assigned to receive daily oral probiotics (Lactobacillus and Bifidobacterium species) or a placebo.

Results: The incidence of NEC was significantly lower in the probiotic group (7.8%) compared to the placebo group (21.6%; p = 0.04). The probiotic group also showed significant reductions in late-onset sepsis (13.7% vs. 29.4%; p = 0.03), shorter hospital stays (42.5 vs. 48.1 days; p = 0.02), and greater weight gain (15.3 vs. 13.4 grams/day; p = 0.01).

Conclusion: These findings support the integration of probiotics into neonatal care, particularly in resource-limited settings.

References

Whelan K, Myers C . Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr. 2010; 91(3):687-703. DOI: 10.3945/ajcn.2009.28759. View

Alfaleh K, Anabrees J . Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014; (4):CD005496. DOI: 10.1002/14651858.CD005496.pub4. View

Sherman P, Ossa J, Johnson-Henry K . Unraveling mechanisms of action of probiotics. Nutr Clin Pract. 2009; 24(1):10-4. DOI: 10.1177/0884533608329231. View

Kelly L, Shah P, Hakansson S, Kusuda S, Adams M, Lee S . Perinatal health services organization for preterm births: a multinational comparison. J Perinatol. 2017; 37(7):762-768. DOI: 10.1038/jp.2017.45. View

Neu J, Walker W . Necrotizing enterocolitis. N Engl J Med. 2011; 364(3):255-64. PMC: 3628622. DOI: 10.1056/NEJMra1005408. View

Sanders M, Akkermans L, Haller D, Hammerman C, Heimbach J, Hormannsperger G . Safety assessment of probiotics for human use. Gut Microbes. 2011; 1(3):164-85. PMC: 3023597. DOI: 10.4161/gmic.1.3.12127. View

Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M . Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005; 147(2):192-6. DOI: 10.1016/j.jpeds.2005.03.054. View

Mercer E, Arrieta M . Probiotics to improve the gut microbiome in premature infants: are we there yet?. Gut Microbes. 2023; 15(1):2201160. PMC: 10153018. DOI: 10.1080/19490976.2023.2201160. View

Rouge C, Goldenberg O, Ferraris L, Berger B, Rochat F, Legrand A . Investigation of the intestinal microbiota in preterm infants using different methods. Anaerobe. 2010; 16(4):362-70. DOI: 10.1016/j.anaerobe.2010.06.002. View

10.

Wang Q, Dong J, Zhu Y . Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg. 2012; 47(1):241-8. DOI: 10.1016/j.jpedsurg.2011.09.064. View

11.

Millar M, Linton C, CADE A, Glancy D, Hall M, Jalal H . Application of 16S rRNA gene PCR to study bowel flora of preterm infants with and without necrotizing enterocolitis. J Clin Microbiol. 1996; 34(10):2506-10. PMC: 229306. DOI: 10.1128/jcm.34.10.2506-2510.1996. View

12.

Robinson J, Rellinger E, Hatch L, Weitkamp J, Speck K, Danko M . Surgical necrotizing enterocolitis. Semin Perinatol. 2016; 41(1):70-79. PMC: 5777619. DOI: 10.1053/j.semperi.2016.09.020. View

13.

Costeloe K, Bowler U, Brocklehurst P, Hardy P, Heal P, Juszczak E . A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial. Health Technol Assess. 2016; 20(66):1-194. PMC: 5027379. DOI: 10.3310/hta20660. View

14.

Patel R, Underwood M . Probiotics and necrotizing enterocolitis. Semin Pediatr Surg. 2017; 27(1):39-46. PMC: 5844696. DOI: 10.1053/j.sempedsurg.2017.11.008. View

15.

Pammi M, Abrams S . Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2011; (10):CD007137. DOI: 10.1002/14651858.CD007137.pub3. View

16.

Beghetti I, Panizza D, Lenzi J, Gori D, Martini S, Corvaglia L . Probiotics for Preventing Necrotizing Enterocolitis in Preterm Infants: A Network Meta-Analysis. Nutrients. 2021; 13(1). PMC: 7827781. DOI: 10.3390/nu13010192. View

17.

Deshpande G, Rao S, Patole S, Bulsara M . Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010; 125(5):921-30. DOI: 10.1542/peds.2009-1301. View

18.

Jacobs S, Tobin J, Opie G, Donath S, Tabrizi S, Pirotta M . Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013; 132(6):1055-62. DOI: 10.1542/peds.2013-1339. View

19.

Underwood M, Salzman N, Bennett S, Barman M, Mills D, Marcobal A . A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. J Pediatr Gastroenterol Nutr. 2009; 48(2):216-25. PMC: 2743418. DOI: 10.1097/MPG.0b013e31818de195. View